30 Apr 2021 --- Resbiotic Inc. has landed US$3 million of seed funding, which will support the development and commercialization of probiotic formulations for lung health. With strategic and manufacturing partners in place, the ResBiotic team is on track to bring its first product to market in early 2022.
